A Study in Subjects With Recurrent Malignant Glioma
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Lenvatinib
Related studies linked through entity extraction aliases.
An Open-Label, 2-Cohort, Multicenter, Study of Lenvatinib in Previously Treated Subjects With Unresectable Stage III or Stage IV Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
A Study of E7080 Alone, and in Combination With Everolimus in Subjects With Unresectable Advanced or Metastatic Renal Cell Carcinoma Following One Prior Vascular Endothelial Growth Factor (VEGF)-Targeted Treatment
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
E7080 (Lenvatinib) in Combination With Dacarbazine Versus Dacarbazine Alone as First Line Therapy in Patients With Stage IV Melanoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
E7080 in Combination With Carboplatin + Gemcitabine Versus Carboplatin + Gemcitabine Alone as Second Line Therapy in Patients With Platinum-Sensitive Recurrent Ovarian Cancer by CA125
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Study of Lenvatinib in Subjects With Advanced Endometrial Cancer and Disease Progression
- Status
- COMPLETED
- Phase
- PHASE2
Study of Lenvatinib (E7080) in Participants With Advanced Hepatocellular Carcinoma (HCC)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
An Open Label Dose Escalation Study Of E7080
- Status
- COMPLETED
- Phase
- PHASE1